Home - Ionis Pharmaceuticals

Spotlight

Dr. C. Frank Bennett Receives Prestigious Breakthrough Prize in Life Sciences in Recognition of the Transformational Drug SPINRAZA® and Ionis’ Antisense Technology

News

November 12, 2018

Phase 2 Results on AKCEA-APO(a)-LRx Presented in Late-Breaking Clinical Trial Presentation at AHA Scientific SessionsMore »

November 9, 2018

Ionis Pharmaceuticals to Host Investor DayMore »

November 8, 2018

Akcea and Ionis Announce Late-Breaking Presentation of Data From AKCEA-APO(a)-LRx at the American Heart Association Scientific SessionsMore »

November 7, 2018

Ionis Pharmaceuticals to Present at Upcoming Investor ConferencesMore »

Events

11-10-2018 - 11-12-2018

AHA Scientific Sessions 2018

Stifel 2018 Healthcare Conference

30th Annual Piper Jaffray Healthcare Conference

Latest Updates

Phase 2 Results on AKCEA-APO(a)-LRx Presented in Late-Breaking Clinical Trial Presentation at AHA Scientific Sessions https://t.co/K8kgegS4KN via @ionispharma

Ionis Pharmaceuticals to Host Investor Day https://t.co/QeMxz0Cvlu via @ionispharma

Follow us

Ionis Clinical Trials

Clinical Trials

We have numerous ongoing clinical trials designed to evaluate our drugs in a variety of health conditions. More »